Improving Adherence and Clinical Outcomes in Self-Guided Internet Treatment for Anxiety and Depression: Randomised Controlled Trial by Titov, N et al.
Improving Adherence and Clinical Outcomes in Self-
Guided Internet Treatment for Anxiety and Depression:
Randomised Controlled Trial
Nickolai Titov1*, Blake F. Dear1, Luke Johnston1, Carolyn Lorian1, Judy Zou1, Bethany Wootton1,
Jay Spence1, Peter M. McEvoy2, Ronald M. Rapee1
1 Centre for Emotional Health, Department of Psychology, Macquarie University, Sydney, Australia, 2 Specialist Clinical Psychologist, Centre for Clinical Interventions and
School of Psychology, University of Western Australia, Perth, Australia
Abstract
Background: Depression and anxiety are common, disabling and chronic. Self-guided internet-delivered treatments are
popular, but few people complete them. New strategies are required to realise their potential.
Aims: To evaluate the effect of automated emails on the effectiveness, safety, and acceptability of a new automated
transdiagnostic self-guided internet-delivered treatment, the Wellbeing Course, for people with depression and anxiety.
Method: A randomised controlled trial was conducted through the website: www.ecentreclinic.org. Two hundred and fifty
seven people with elevated symptoms were randomly allocated to the 8 week course either with or without automated
emails, or to a waitlist control group. Primary outcome measures were the Patient Health Questionnaire 9-Item (PHQ-9) and
the Generalized Anxiety Disorder 7-Item (GAD-7).
Results: Participants in the treatment groups had lower PHQ-9 and GAD-7 scores at post-treatment than controls.
Automated emails increased rates of course completion (58% vs. 35%), and improved outcomes in a subsample with
elevated symptoms.
Conclusions: The new self-guided course was beneficial, and automated emails facilitated outcomes. Further attention to
strategies that facilitate adherence, learning, and safety will help realise the potential of self-guided interventions.
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Introduction
The World Mental Health Surveys indicate that globally more
than 500 million people each year meet diagnostic criteria for
anxiety and depressive disorders [1]. Effective psychological
treatments for these conditions are increasingly available via the
internet (internet psychotherapy; iPT), which offers improved
accessibility and convenience for both patients and clinicians [2].
Disorder-specific iPT interventions are clinically effective for
adults with anxiety disorders and depression when guided by a
therapist [3,4,5,6]. Recent work indicates that transdiagnostic iPT
interventions, which treat symptoms of both anxiety and
depression in the same intervention, are also efficacious when
administered by a therapist [7,8,9]. However, many consumers
prefer and opt for self-guided iPT over therapist-guided versions.
For example, recent research by a large iPT clinic found that only
75 of 2660 (i.e., 2%) consecutive participants elected for therapist-
guided iPT over self-guided iPT [10].
Publicly available self-guided iPT interventions are popular. For
example, the Panic Center (www.paniccentre.net) and Moodgym
(www.moodgym.anu.edu.au), which offer disorder-specific and
self-guided online interventions, each have more than 400,000
registered users. Unfortunately, while data indicate that those who
adhere and complete these interventions obtain good outcomes
[11,12,13], the full public health potential of self-guided iPT has
arguably not yet been realised. Typically more than 90% of
consumers withdraw after two sessions and, thus, are unlikely to
receive a ‘dose’ of therapeutic content sufficient to lead to
sustained improvement. Self-guided transdiagnostic iPT interven-
tions which include strategies that facilitate adherence have
considerable potential for greater outcomes while providing
clinically and cost effective treatment to large numbers of people.
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One strategy for improving adherence is to utilise reminders
that promote both exposure to therapeutic content and practice of
therapeutic skills [14]. Surprisingly, very few self-guided iPT
interventions provide reminders. However, a trial of self-guided
iPT for depression [15] demonstrated that reminders increased
clinical symptom reductions relative to an earlier trial without
reminders [16] and evidence that effect was more pronounced in
participants who were more severely depressed at pre-treatment.
Similarly, comparisons across trials of iPT for adults with social
phobia show that automated reminder emails increased comple-
tion rates and effect sizes relative to earlier trials without
automated reminders [17,18,19]. Automated emails may be
particularly suitable as a medium for providing reminders given
the extremely low cost of emails and their ubiquity. Moreover,
emerging studies are also indicating that emails can be used as a
stand-alone self-help measure with sub-threshold depression to
produce small but significant changes in symptom levels [20].
However, despite this emerging evidence and their potential, no
studies have directly or systematically explored the ability of
automated reminders in self-guided iPT to improve adherence and
clinical outcomes.
The primary aim of the current study was to determine whether
automated emails improved adherence and clinical outcomes
during a new transdiagnostic self-guided iPT intervention, the
Wellbeing Course, designed to treat symptoms of depression and
anxiety. A secondary aim of the current study was to provide
preliminary data about participant safety and the acceptability of
the intervention. The study design simulated an automated and
publically available website, where consumers applied and
completed the intervention with no contact with staff. It was
hypothesized that (1) automated emails would enhance completion
rates and reductions on clinical symptoms, and (2) automated
emails would be particularly beneficial for participants with
elevated symptoms. No hypotheses were developed with respect
to the acceptability or safety of the Wellbeing Course.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Ethics Statement and Trial Registration
The study was approved by the Human Research Ethics
Committee (HREC) of the University of New South Wales
(UNSW, Sydney, Australia) and ratified by the Macquarie
University HREC (Sydney, Australia; HREC Reference:
5201100226). The original protocol included telephone interviews
at recruitment and a fourth group who received weekly contact
with a therapist. However, in order to focus on the benefits of
providing automatic emails during self-guided treatment and to
simulate an entirely automated treatment process, the interviews
and this fourth group were omitted from the final design. This
change was approved by the UNSW HREC. The trial is registered
with the Australian and New Zealand Clinical Trials registry as
ACTRN12610001058066 and complies with updated CON-
SORT recommendations [21].
Design and Sample Size
Eligible applicants were randomly allocated to one of two
treatment groups or to a waitlist-deferred treatment control group.
Participants in the Treatment Plus Automated Email Group
(TEG; n = 100) received access to the Wellbeing Course with
automated emails. Participants in the Treatment Group (TG;
n = 106) received access to the Wellbeing Course without
automated emails. The Control Group (Control; n = 51) received
access to the same treatment as the TEG group following post-
treatment.
A weighted randomisation procedure was employed in which
40% of successful applicants were assigned to each treatment
group and 20% were assigned to the control group. A priori power
analysis indicated that 246 participants would be sufficient to
detect a between-treatment group (Cohen’s d) effect size (ES)
difference $0.35 between the two treatment groups and an ES
difference $0.55 between the treatment and control groups with
alpha at.05 (one-tailed) and power of.80). These ESs were deemed
sufficient, based on similar studies [22,23] but more were recruited
to hedge against attrition.
A colleague in another country used the website www.random.
org to create a list of 300 randomly generated numbers. These
were numbers were sorted by size and the highest 20% and lowest
40% were marked to indicated they referred to the control group
and the TG, respectively. The remainder were marked to indicate
they belong to the TEG. The list was then returned to its original
order and was used to automatically assign applicants to a
condition.
Participants and Recruitment
Participants were automatically recruited from visitors to a
research website that evaluates internet-delivered treatments
(www.ecentreclinic.org). After reading about the study and
providing informed consent, applicants completed online ques-
tionnaires enquiring about symptoms of mood and anxiety,
demographic details and treatment history.
During the seven weeks of recruitment in mid-2011, 381
individuals applied for this trial, and 274 met the following
inclusion criteria: (i) Resident of Australia and at least 18 years of
age; (ii) self-identified as having a principal complaint of
depression, generalised anxiety disorder (GAD), social phobia, or
panic disorder as indicated by total scores on at least one of the
following measures: Patient Health Questionnaire-9 Item (PHQ-9)
.9; [24,25] Generalised Anxiety Disorder-7 Item (GAD-7) .7;
[26,27] MINI Social Phobia Inventory (MINI-SPIN) .5; [28]
Autonomic Nervous System Questionnaire (ANSQ) .1, [29]
indicating likely diagnoses of depression, GAD, social phobia, and
panic disorder, respectively; (iii) not currently participating in
cognitive behavior therapy (CBT); (iv) no change in medications in
the period 1 month prior to this study; (v) not currently
experiencing a psychotic mental illness or severe symptoms of
depression (defined as a total score $23 or responding .2 to
Question 9 (suicidal ideation) on the PHQ-9; (vi) had reliable
Internet access; (vii) provided personal contact details.
Measures
The GAD-7, PHQ-9, MINI-SPIN and ANSQ were employed
in the present trial as preliminary measures ensure participants
had clinical level symptoms and were eligible for the trial. These
measures are all widely used and all how high levels of sensitivity
(i.e., $.75) and specificity (i.e., $.75), except the ANSQ which
shows high levels of sensitivity (range:.94 to 1.00) but low levels of
specificity (Range:.25 to.59) [24–29].
The primary outcome measures were severity of symptoms of
depression and anxiety, measured by the PHQ-9 and GAD-7,
which are based on the DSM-IV diagnostic criteria for depression
and GAD, respectively. The GAD-7 has good convergent validity
with other anxiety scales [25], is sensitive to DSM-IV congruent
GAD, social phobia, and panic disorder, with increasing scores
indicating greater symptom severity [27]. The GAD-7 is
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increasingly used in research and in large scale dissemination
studies as a generic measure of change in anxiety symptoms
[30,31]. A total score of 10 on the PHQ-9 has been identified as an
important threshold for identifying DSM-IV congruent depression
with increasing scores indicating greater symptom severity, while
psychometric studies indicate the measure is sensitive to change
[24,25,32].
Secondary outcome measures included treatment satisfaction
and completion rates (i.e., percentage in each treatment group
who read the five online lessons of the Wellbeing Course within
the 8 weeks of the course). Additional measures included changes
in health status and service utilisation, which will be reported
elsewhere.
TEG and TG participants completed the PHQ-9 and GAD-7 at
pre-treatment, prior to each of the five lessons of the Wellbeing
Course, at post-treatment, and again at 3-month follow-up. The
satisfaction measures were administered at post-treatment. Con-
trols completed the PHQ-9 and GAD-7 at the pre-and post-
treatment time points of the treatment groups, and then began
treatment.
Intervention
The Wellbeing Course is a new five lesson transdiagnostic
online intervention based on models of cognitive behavioural and
interpersonal therapies. The original Wellbeing Program devel-
oped by the researchers [8,9] was not available when the
researchers moved institutions and, consequently, a new interven-
tion was developed. This new course is based on a pragmatic
model of psychotherapeutic change that assumes that symptoms of
anxiety and depression are the result of unhelpful habits of thought
and actions, that is, maladaptive cognitions and behaviours. Such
unhelpful habits often develop over months or years and may
become an entrenched part of a person’s life. This model also
assumes that interventions that are structured, systematic, and
which require adherence and commitment over several months
are more likely to facilitate sustained improvements than sporadic
or unstructured therapy sessions, which may only result in short-
term symptom relief.
Thus, the Wellbeing Course is a structured intervention that
participants complete over an 8 week period. Participants are
strongly encouraged to learn about and practice the psychological
skills taught in the course, and to adopt these into their everyday
lives. The course systematically teaches core psychological skills
that aim to increase the frequency of cognitions and behaviours
that promote emotional health, and reduce those that maintain
distressing symptoms. Examples of the former include realistic
thinking skills, planning, and problem solving skills, assertive
communication, behavioural activation, and graded exposure.
Examples of the latter include patterns of catastrophic and self-
defeating thinking, passive or aggressive communication styles,
avoidance, and behavioural inhibition. By doing so, this Course
targets symptoms common to anxiety disorders and depression.
The Wellbeing Course was designed as a low intensity interven-
tion, which could be used as a standalone intervention, an
intervention for those on waiting lists for traditional therapy, as an
adjunct to traditional therapy, or to facilitate treatment gains post-
treatment.
The Course comprises material both in didactic form, that is,
text based instructions and information, and case-enhanced
learning examples. Case-enhanced learning is informed by
principles of Social Cognitive Theory (SCT) [33] and uses
educational stories that identify a problem and a solution which
an example (i.e., a case) resolves for the learner. The use of cases to
facilitate learning is thought to assist in learning, adherence and
engagement [34] while reducing defensiveness [34,35,36].
Lesson 1 of the Wellbeing Course includes information about
the prevalence of anxiety disorders and depression, their role in
affecting achievement of life goals, and how cognitive, behaviour-
al, and physical symptoms maintain poor emotional health. Lesson
2 describes strategies for developing realistic cognitions. Lesson 3
describes physical de-arousal strategies and strategies for re-
engaging in reinforcing activities. Lesson 4 describes avoidance
and safety behaviours and principles of graded exposure. Lesson 5
describes principles of relapse prevention.
Each lesson is presented in a slide format combining text and
photos, with approximately 60 slides per lesson, and 50 words per
slide. Automated analyses of readability indicate the text has a
mean Flesch-Kincaid Grade level of 6.1, a Simple Measure of
Gobbledygook (SMOG) Index of 7, and Automated Readability
Index of 5.3, indicating suitability for 8–9 year olds. Participants
are instructed to read lessons in order over 8 weeks. Lessons 1, 2,
3, 4, and 5 are available at the beginning of weeks 1, 2, 4, 5, and 7,
respectively. This timetable provides participants with additional
time for the most complex components of the intervention, namely
skills for managing cognitive and behavioural symptoms. Recom-
mended homework assignments are described in a Do It Yourself
Guide for each lesson. Additional resources include materials about
assertiveness, communication and problem solving skills, and sleep
hygiene skills.
Procedure
TG and TEG participants received an email at the start of the
Course providing guidelines and a recommended timetable to get
the most out of the Course. TEG participants also received at least
two additional emails per week during the Course. Some emails
were triggered based on participant behaviour: specifically, emails
were triggered when (1) participants completed each Lesson
during the Course, and (2) if participants had not completed a
Lesson within 7 days of it becoming available. Emails were also
triggered according to the Course timeline: specifically, emails
were triggered (1) at the beginning of each week when new Lessons
became available or, if no new Lessons became available, to
suggest some tasks for the week, and (2) at set times when
participants were known to experience increases in symptoms or to
have increased difficulties practicing skills (e.g., during the weeks
where graded exposure is introduced). The emails were written
and designed to (1) make sure participants always new about new
content available on the site, (2) remind participants about unread
materials, (3) reinforce progress and skills practice, (4) ‘normalise’
the challenges of learning new skills, and (5) emphasise and explain
that symptom reduction required gentle, but consistent, practice of
the skills over time. Each email was brief and was comprised of 2
to 3 paragraphs containing 3 or 4 concise sentences. Each email
used the participant’s first name and was written to convey a warm
and supportive tone. All participants consented to receive the
emails and no emails contained personal or detailed clinical
information.
Controls completed pre-treatment questionnaires at the same
time as the treatment groups, but had no further contact with the
researchers until post-treatment. Control group participants then
received the same post-treatment questionnaires as the treatment
groups and began treatment as soon as these questionnaires were
complete. The control group participants received the same
treatment as the TEG.
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Statistical Methods
Participants who did not complete pre-treatment questionnaires
were not included in any analyses. This was necessary as
participants began the intervention in cohorts following randomi-
sation. Group differences in demographic data and pre-treatment
measures were analysed with one-way analysis of variance
(ANOVAs) followed by t-tests with Bonferroni corrected p values
and chi-square tests.
Two sets of analyses were conducted to examine the primary
hypotheses. The mixed-models approach with an autoregressive
covariance structured and using maximum likelihood estimation
was identified as the best way to handle missing data at post-
treatment and three month follow-up. The first set of analyses
were conducted using the entire data set (i.e., the Overall Sample)
and the second set of analyses were restricted to participants with
elevated symptoms of both anxiety and depression (i.e., the
Comorbid Sample), defined by pre-treatment scores above clinical
cut-offs on both primary outcome measures (i.e., GAD-7$8 and
total PHQ-9$10). Differences in questionnaire scores within and
between groups at the different time points were examined using
pairwise comparisons. Effect sizes (Cohen’s d) and 95% effect size
confidence intervals were calculated both within-group and
between-group effects based on the pooled standard deviation.
All analyses were performed in SPSS version 19.0 (SPSS, Inc.,
Chicago, IL).
As described in recent dissemination studies [31], pre-treatment,
post-treatment and follow-up PHQ-9 and GAD-7 scores were
compared with clinical cut-offs to provide an index of clinically
significant remission. This was defined as the proportion of
participants who initially scored at or above the clinical cut-offs
and then subsequently below the clinical cut-offs. Finally, the
number of times safety protocols were triggered because of
elevated PHQ-9 scores and the proportion of participants with
significant deterioration in PHQ-9 or GAD-7 scores were
reported. The latter was calculated for each group based on a
completer analysis and defined as an increase in PHQ-9 or GAD-7
scores of 5 or more points from pre-treatment.
Results
Baseline Data
The mean age of participants was 41.30 years (SD = 9.76), and
186 (74.4%) were women. Additional demographic details are
included in Table 1. A one way ANOVA and post-hoc tests
revealed that Controls were older than TEG participants (F2,
254 = 3.42, P = .034), and TG participants were less likely to be
taking medication for mental health conditions than other
participants (x2 (2) = 6.20, P = .013). No other differences were
found in demographic characteristics or in pre-treatment scores on
the outcome measures (all Ps..05).
Adherence and Attrition
The flow is shown in Figure 1. More TEG participants (58.0%)
completed the course, defined as reading the five lessons within the
eight weeks, than TG (35.8%) participants (x2 (1) = 10.15,
P = .001) in the Overall Sample. A similar pattern was observed
in the Comorbid Sample with more TEG participants (56.7%)
completing the course than TG (29.6%) participants (x2 (1) = 8.44,
P = .004). As indicated in Figure 1, considerably more TG
participants (34.0%) terminated before completing lesson 3 than
TEG participants (11.0%). Completers did not differ from non-
completers on either PHQ-9 or GAD-7 pre-treatment scores (F1,
204 = 0.39–1.67, P..05).
Post-treatment data were collected from 84.0% TEG, 86.8%
TG, and 84.3% Control participants. Three-month follow-up data
were collected from 79.0% TEG and 79.2% TG participants.
ANOVAs revealed that those who did not complete follow-up
questionnaires had significantly higher pre-treatment PHQ-9
scores (F1, 204 = 9.33, P = .003) but not GAD-7 scores (F1,
204 = 0.06, P = .80), than questionnaire completers.
Primary Outcome Measures
Means for the PHQ-9 and GAD-7 for the Overall and
Comorbid Samples are included in Table 2. The means for the
Control Group after they received the same treatment as the TEG
are also shown in Table 2. Changes in PHQ-9 and GAD-7 scores
for the Overall and Comorbid Samples are shown in Figure 2.
Overall Sample. The mixed-models analyses examining
PHQ-9 scores (Table 2) revealed a significant effect for Time
(F2, 373 = 61.66, P,.001) and a significant Time by Group
interaction, (F3, 416 = 6.79, P,.001), but no significant effect for
Group (F2, 277 = 1.882, P = .154). Pairwise comparisons revealed
significant differences between TEG and Controls (P,.001) and
between TG and Controls (P = .001) at post-treatment, but no
significant difference between treatment groups at post-treatment
(P = .333) or three month follow-up (P = .611).
Similarly, the analyses examining GAD-7 scores revealed a
significant effect for Time (F2, 370 = 105.07, P,.001) and a
significant Time by Group interaction, (F3, 416 = 7.43, P,.001),
but no significant effect for Group (F2, 269 = 0.487, P = .615).
Pairwise comparisons revealed significant differences between
TEG and Controls (P = .001) and between TG and Controls
(P = .0028) at post-treatment, but no significant difference between
treatment groups at post-treatment (P = .151) or three month
follow-up (P = .505).
Comorbid Sample. The mixed-models analyses examining
PHQ-9 scores (Table 2) for the Comorbid Sample revealed a
significant effect for Time (F2, 158 = 76.81, P,.001) and Group (F1,
107 = 5.03, P = .027), and a significant Time by Group interaction,
(F2, 158 = 4.03, P = .020. Pairwise comparisons revealed that both
groups improved significantly from pre-treatment to post-treat-
ment (Ps,.001), but not from post-treatment to follow-up
(P..099). However, the pairwise comparisons also revealed
significant differences between TEG and TG Groups at post-
treatment (P = .008) and three month follow-up (P = .015) with the
TEG Group reporting lower symptoms on the PHQ-9 at both
time points.
The analyses examining GAD-7 scores revealed a significant
Time by Group interaction, (F2, 150 = 3.78, P = .025) and
significant main effects for Time (F2, 150 = 106.34, P,.001) and
Group (F1, 99 = 5.51, P = .021). Pairwise comparisons revealed that
both groups improved significantly from pre-treatment to post-
treatment (Ps,.001), but that the TG Group improved signifi-
cantly from post-treatment to follow-up (P = .033) where the TEG
Group showed no significant change in GAD-7 scores from post-
treatment to follow-up (P = .320). The pairwise comparisons also
revealed the TEG Group reported significantly lower symptoms
than the TG Group at post-treatment (P = .002) and three month
follow-up (P = .031).
Effect Sizes
Within- and between-group effect sizes for the outcome
measures are included in Tables 2 and 3. For both the Overall
and Comorbid Samples large ($0.8) within-group effect sizes were
found for the TEG, and moderate (0.5,0.8) to large within-group
effect sizes were found for the TG. Small (,0.5) between-group
effect sizes were found between the two treatment groups, while
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moderate between-group effect sizes were found for the diagnostic
samples.
Clinical Significance
Overall Sample. With respect to remission, significantly
more TEG (55.9% and 57.9%) and more TG (53.7% and 56.8%)
participants scored below the PHQ-9 and GAD-7 clinical cut-offs
than Controls (24.1% and 21.9%) at post-treatment, respectively,
with no difference between treatment groups (Table 4). These
gains were sustained at follow-up, again with no difference
between treatment groups.
Comorbid Sample. At post-treatment, significantly more
TEG (46.7%) and TG (38.9%) participants were below both cut-
offs than Controls (18.2%), with no difference between treatment
groups (Table 4). These levels of remission were sustained at
follow-up, again with no difference between treatment groups.
Treatment Satisfaction
At post-treatment, 71/74 (95.9%) TEG and 76/80 (95%) TG
participants reported it was ‘worth their time doing the course’, and 72/
74 (97.3%) TGE and 74/79 (93.7%) TG participants reported
they would ‘recommend this course to a friend with anxiety or depression’.
Chi-squared analyses failed to reveal any differences in these
satisfaction ratings (x2 (2–3) range = 0.76–2.82, P..05).
Safety
Participants’ responses to the PHQ-9 were automatically
monitored and those whose PHQ-9 total scores increased from
pre-treatment by more than 5 points and who also had a total
score of $15, indicating the presence of moderately severe
depression were sent an automated email providing instructions
about how to contact crisis services in the event of a mental
health emergency. Those whose PHQ-9 scores were above 20,
indicating severe depression, or scoring ‘3’ to question 9 of the
PHQ-9, were telephoned by the researchers who conducted an
assessment and provided management. Five (5.0%) TEG, 1.9%
TG, and no Controls received emails, and an additional 3.0%
TEG, 2.8% TG, and 2.0% Control participants received both
telephone calls and emails. The remainder of participants did
not receive contact from the researchers until the 8 weeks had
elapsed.
Table 1. Group demographic characteristics for the Overall Sample.
TEG (n = 100) TG (n = 106) Controls (n = 51) Total
Statistical
Significance
Variable n % n % n % N %
Sex
Male 23 23 28 26.4 17 33.3 68 26.5 x2 (2) = 1.85, P = 0.396
Female 77 77 78 73.6 34 66.7 189 73.5
Age
Mean 40.31 (10.13) – 40.71 (9.07) – 44.45 (9.97) – 41.30 (9.76) – F2,254 = 3.42, P = 0.034
Range 18–59 – 20–58 – 22–59 – 18–59 –
Self-Identified Principal Problem
Depression 33 33.0 29 27.4 23 45.1 85 33.1 x2 (6) = 9.69, P = 0.138
Generalised Anxiety Disorder 28 28.0 44 41.5 12 23.5 84 32.7
Panic Disorder 17 17.0 11 10.4 6 11.8 34 13.2
Social Phobia 22 22.0 22 20.8 10 19.6 54 21.0
Marital Status
Single/Never Married 31 31.0 25 23.6 12 23.5 68 26.5 x2 (4) = 7.18, P = 0.127
Married/De Facto 57 57.0 70 66.0 27 52.9 154 59.9
Separated/Divorced/Widowed 12 12.0 11 10.4 12 23.5 35 13.6
Education
None 1 1.0 0 0.0 0 0.0 1 0.4 x2 (6) = 3.99, P = 0.677
High school 19 19.0 18 17.0 9 17.6 46 17.9
Trade/Technical Certificate 21 21.0 15 14.2 8 15.7 44 17.1
Diploma/Degree 59 59.0 73 68.9 34 66.7 166 64.6
Employment Status
Full time 49 49.0 49 46.2 18 35.3 116 45.1 x2 (4) = 5.26, p = .325
Part time/Student 31 31.0 34 32.1 18 35.3 83 32.3
Unemployed, Retired or Disabled 20 20.0 23 21.7 15 29.4 58 22.6
Previous Mental Health Treatment 84 84.0 87 82.1 41 80.4 212 82.5 x2 (2) = 0.326,
P = 0.850
Taking Medication for Mental Health
Condition
45 45.0 30 28.3 24 47.1 99 38.5 x2 (2) = 8.02, P = 0.018
Note. TEG: Treatment Plus Automated Email Group. TG: Treatment Group.
doi:10.1371/journal.pone.0062873.t001
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Deterioration
Overall Sample. At post-treatment and follow-up up to 4.0%
of TEG, 7.5% of TG and 13.7% of Control participants obtained
PHQ-9 or GAD-7 scores five or more points higher compared to
pre-treatment.
Comorbid Sample. At post-treatment and follow-up, up to
2.0% of TEG, 7.5% of TG and 5.9% of Control participants
obtained PHQ-9 or GAD-7 scores five or more points higher
compared to pre-treatment.
Control Group Participants
Forty one of the 51 Control group participants elected to begin
the Wellbeing Course after the Treatment Groups completed, and
received the same treatment as the TEG. Twenty two of 41
(53.7%) Control Group participants completed the course within
the 8 weeks, and post-treatment data and 3-month follow-up were
collected from 87.8% and 87.8% participants, respectively.
The mixed-models analyses on the Control Group during
treatment revealed significant main effects for Time on both the
PHQ-9 (F2, 69 = 21.11, P,.001) and GAD-7 (F2, 68 = 14.55,
P,.001). Pairwise comparisons revealed significant improvements
on both the PHQ-9 and GAD-7 from pre-treatment to post-
treatment (P,.001), but not post-treatment to 3-month follow-up
(P..257). These changes corresponded to effect sizes from pre-
treatment to follow-up of 0.88 and 0.92 on the PHQ-9 and GAD-
7, respectively.
With respect to remission, at post-treatment, 69.6% and 61.5%
of Control Group participants scored below the PHQ-9 and
GAD-7 clinical cut-offs, respectively, and these gains were
sustained at follow-up. Ninety seven percent of Control group
participants reported it was worth their time doing the Course,
and 94% reported they would refer a friend.
Discussion
The Wellbeing Course resulted in clinically significant reduc-
tions in symptoms of anxiety and depression related to a waitlist
control group. These results indicated automated emails increased
completion rates in a self-guided iPT intervention for people with
anxiety and depression from 36% to 58%. No overall differences
were found between participants who did and did not receive
automated emails during the intervention in symptoms of anxiety
or depression at post-treatment or follow-up. However, significant
differences were found between participants who did or did not
receive emails for elevated symptoms of both anxiety and
Figure 1. Wellbeing study flow chart. PHQ-9, Patient Health Questionnaire –9 Item. TEG: Treatment Plus Automated Email Group. TG: Treatment
Group.
doi:10.1371/journal.pone.0062873.g001
Figure 2. Means for the PHQ-9 and GAD-7 for the Overall and Comorbid Samples. Note: TEG: Treatment plus automated email group. TG:
Treatment group. PHQ-9: Patient Health Questionnaire-9 Item. GAD-7: Generalised Anxiety Disorder-7 Item.
doi:10.1371/journal.pone.0062873.g002
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depression. Specifically, those participants with elevated symptoms
who received automated emails reported significantly less symp-
toms of anxiety and depression at post-treatment and follow-up
compared with those who did not. These differences corresponded
to moderate between-group effect sizes at post-treatment (d = 0.56
and 0.65) and follow-up (d = 0.45 and 0.51). Importantly,
treatment satisfaction was high and the results were replicated in
the Control Group, providing preliminary evidence for the
reliability of automated emails in facilitating outcomes.
The present results are consistent with previous studies reporting
the effectiveness of automated self-guided internet treatments for
depression or anxiety, but are of a greater magnitude [12,13,15,37].
These results also compare favourably with those obtained from
trials of transdiagnostic iPT involving clinician guidance [7,8,9],
trials of clinician-guided transdiagnostic interventions administered
face-to-face [38], and with results from implementation trials in the
UK IAPT service [31]. However, caution should be exercised in
making comparisons across studies due to differences in samples,
inclusion criteria, and methodologies.
The overall results indicate that adding automated emails can
facilitate adherence and outcomes in self-guided internet-delivered
interventions. These benefits are stronger for those with comorbid
and more severe symptoms. Unfortunately, no firm conclusions can
be drawn concerning how emails facilitated adherence or clinical
outcomes in the present trial. However, the results parallel an
extensive literature that indicates the benefits of minimal therapist
contact added to self-help programs [39,40]. Within this context
therapists are likely to enhance motivation to continue in the course
and engage in therapeutic activities. It is possible that automated
emails serve the same motivational purpose and act in a similar
fashion to a therapist, albeit in a less costly manner. If this is true, it
would suggest that maximising the motivational efficacy or tailoring
of automated emails might produce even stronger effects.
Implications
These results indicate that, contrary to earlier reports [41],
outcomes of self-guided internet-delivered interventions are
beginning to approximate those obtained when support is
provided by a therapist, at least, for populations attracted to
online clinical trials. These results provide support for a model of
psychotherapeutic change that emphasises the importance of
systematically learning, practicing, and adopting core psycholog-
ical skills that help to change unhelpful habits of thought and
action. Systematically examining other strategies to promote
engagement and adherence in self-guided iPT interventions is
likely to further improve outcomes in iPT and will also have utility
across a broad range of health conditions. We suspect the use of
case-enhanced learning strategies in the course content facilitated
engagement and adherence and, as noted by others, providing a
clear deadline and expectations of feedback may also facilitate
adherence and clinical outcomes [38].
Clinically effective self-guided iPT interventions are likely to be
integrated with traditional models of care as therapists are more
likely to refer consumers to self-guided interventions that are
acceptable, engaging and effective. The results of the present study
extend recent studies indicating that, following a therapist-
administered structured diagnostic interview, consumers can
obtain considerable benefit from a self-guided iPT intervention
[17,42,43,44]. Those who do not benefit from the self-guided
intervention or who wish for more support can be subsequently
referred for a more intense intervention. This simple stepped
model has considerable potential for improving the capacity of
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Notwithstanding these encouraging findings, these results
indicate that risk of deterioration is not insignificant. Between 5
and 8% of treatment group participants required intervention and,
although this proportion will vary depending on the criteria used,
they indicate that some people accessing publicly available
websites will have significant psychological distress. Consequently,
attention must be given to protocols for facilitating safety and
referral to crisis services.
Limitations
The generalisability of these findings needs to be considered in
the context of the research design and participants. We aimed to
simulate an intervention available on an open-access website.
Thus, although participants applied independently and did not
have contact with researchers until post-treatment, they were
required to apply for the trial raising the potential of self-selected
bias. However, a recent comparison of demographic and symptom
profiles of participants in internet trials with those identified in
epidemiological samples indicates the results of such trials may
generalise to the wider population [45], although those results
should be replicated with other samples. Unfortunately, no firm
conclusions can be drawn concerning mechanisms through which
emails facilitated outcomes and it is also notable that, in the overall
sample, significant improvements in clinical outcomes were
observed despite many participants not completing the whole
Course. This is likely explained by the fact that, despite not
completing the Course, most participants were exposed to
significant levels of clinical content. Future research would,
however, benefit from focusing on what level of clinical content
is required to be reviewed or used in order to maximize and
sustain clinical outcomes over the longer term.
While significant improvements were observed on symptoms of
anxiety and depression, we did not conduct analyses on symptom
measures relevant to specific anxiety disorders. In order to
simulate an automated and publically available website the
present study also had to rely on self-report measures. Thus, these
results do not address questions concerning whether a transdiag-
nostic approach produces results comparable to disorder-specific
interventions and future research may benefit from using non self-
report based measures such as structured diagnostic interviews at
follow-up time points. We have begun trials to explore and address
both of these issues. In addition, the thresholds we used for
triggering safety protocols and for determining clinically significant
deterioration reflect the pragmatic requirements of this trial, and
may not apply in other situations.
Conclusions
The present results indicate that self-guided transdiagnostic iPT
interventions can be developed, which result in clinically
significant outcomes on generic measures of anxiety and
depression and are acceptable to consumers. The inclusion of
automated emails facilitated adherence and completion, particu-
larly for those with comorbid or elevated symptoms. Replication is
required with samples that include those with subclinical
symptoms. Direct comparisons with disorder-specific programs
are also necessary to determine the benefits of the Wellbeing
Course for people with specific diagnoses. Further attention to
developing strategies that facilitate adherence, engagement,
learning and consumer safety are likely to help realise the
potential of self-guided interventions.
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Table 4. Proportion of participants in the Overall and Diagnostic Sample, by group, above and below cut-off scores of clinical
significance (remission).
Overall Sample TEG TG Control Chi Square
n % n % n % Between group TGE vs. TG
PHQ-9
Pre-treatment score $10/Total 68/100 68.0 67/106 63.2 29/51 56.9 x2 (2) = 1.84, P = 0.398
Post-treatment score ,10 (Remission) 38/68 55.9 36/67 53.7 7/29 24.1 x2 (2) = 9.05, P = 0.011 x2 (1) = 0.06, P = 0.802
Follow-up score ,10 (Remission) 45/68 66.2 42/67 62.7 – – x2 (1) = 0.18, P = 0.672
GAD-7
Pre-treatment score $8/Total 76/100 76.0 74/106 69.8 32/51 62.7 x2 (2) = 2.96, P = 0.228
Post-treatment score ,8 (Remission) 44/76 57.9 42/74 56.8 7/32 21.9 x2 (2) = 13.20, P = 0.001 x2 (1) = 0.02, P = 0.888
Follow-up score ,8 (Remission) 45/76 59.2 44/74 60.3 – – x2 (1) = 0.00, P = 0.975
Diagnostic Sample
Pre-treatment PHQ-9 score $10 and
GAD-7 score $8/Total
60/100 60.0 54/106 50.9 22/51 43.1 x2 (2) = 4.14, P = 0.126
Post-treatment PHQ-9 score ,10 and
GAD-7 score ,8 (Remission)
28/60 46.7 21/54 38.9 4/22 18.2 x2 (2) = 5.49, P = 0.064 x2 (1) = 0.70, P = 0.402
Follow-up PHQ-9 score ,10 and GAD-7
score ,8 (Remission)
30/60 50.0 23/54 42.6 – – x2 (1) = 0.63, P = 0.429
Note. TEG: Treatment Plus Automated Email Group. TG: Treatment Group.
doi:10.1371/journal.pone.0062873.t004
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